Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticGraft SurvivalKidney TransplantationTissue DonorsLeukemiaTransplantation ChimeraLiver TransplantationBusulfanHistocompatibility TestingBone Marrow PurgingHistocompatibilityCyclophosphamideHematopoietic Stem CellsGraft RejectionTransplantation, IsogeneicMedical OncologyImmunosuppressive AgentsBone Marrow DiseasesTreatment OutcomeRecurrenceCombined Modality TherapyHematopoiesisHeart TransplantationTime FactorsMice, Inbred C57BLRadiation ChimeraLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyRemission InductionImmunosuppressionLung TransplantationHepatic Veno-Occlusive DiseaseRetrospective StudiesBone RemodelingBone Marrow NeoplasmsSurvival AnalysisStem Cell TransplantationLeukemia, MyeloidGraft vs Host ReactionAcute DiseaseLymphoma, Non-HodgkinLymphocyte DepletionCyclosporineLeukocyte TransfusionHLA AntigensAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesSevere Combined ImmunodeficiencyChimeraMyelodysplastic SyndromesColony-Forming Units AssayHematologic DiseasesSurvival RateFollow-Up StudiesCytomegalovirus InfectionsActuarial AnalysisOncology NursingTransplantationLymphocyte TransfusionBone DensityDisease-Free SurvivalNuclear FamilyTransplantsCarmustineCytarabineGraft vs Tumor EffectCell DifferentiationOrgan TransplantationGraft vs Leukemia EffectPancytopeniaLeukocyte CountEtoposidePrognosisGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CSpleenPostoperative ComplicationsLymphomaMultiple MyelomaBone ResorptionLiving DonorsFlow CytometryFatal OutcomeNeoplasmsAntilymphocyte Serum